Abits
ABTS
Bit Origin
BTOG
TeraWulf
WULF
BIGG DIGITAL ASSETS INC
BBKCF
NEPTUNE DIGITAL ASSETS CORP
NPPTF
US Stock MarketDetailed Quotes
EBS Emergent BioSolutions
- 9.560
- +0.310+3.35%
Close Dec 31 16:00 ET
- 9.610
- +0.050+0.52%
Post 18:03 ET
518.00MMarket Cap-2.45P/E (TTM)
9.852High9.150Low2.04MVolume9.260Open9.250Pre Close19.46MTurnover3.84%Turnover RatioLossP/E (Static)54.18MShares15.10052wk High1.02P/B508.51MFloat Cap1.42052wk Low--Dividend TTM53.19MShs Float137.610Historical High--Div YieldTTM7.59%Amplitude1.420Historical Low9.533Avg Price1Lot Size
About Emergent BioSolutions Company
Emergent BioSolutions Inc. engages in the development, manufacture, and commercialization of medical countermeasures. It offers products for civilian and military populations that address accidental, intentional, and naturally occurring public health threats. The firm's products include ACAM2000, BioThrax, Raxibacuma, Vaxchora, and VIGIV. Its business units include Vaccines and Anti-Infectives, Antibody Therapeutics, Devices, and Contract Development and Manufacturing. The company was founded by Fuad El-Hibri on September 5, 1998 and is headquartered in Gaithersburg, MD.
Company Profile
SymbolEBS
Company NameEmergent BioSolutions
Listing DateOct 2, 2009
Issue Price12.50
Founded1998
CEOMr. Joseph C. Papa
MarketNYSE
Employees1600
Fiscal Year Ends12-31
Address300 Professional Drive,Suite 400
CityGaithersburg
ProvinceMaryland
CountryUnited States of America
Zip Code20879
Phone1-240-631-3200
Company Executives
- Name
- Position
- Salary
- Joseph C. Papa
- Director, President and Chief Executive Officer
- --
- Richard S. Lindahl
- Principal Accounting Officer, Executive Vice President, Chief Financial Officer and Treasurer
- 2.18M
- Paul Williams
- Senior Vice President, Products Business
- 1.06M
- Coleen Glessner
- Executive Vice President, Quality and Ethics and Compliance
- 1.68M
- Dr. Zsolt Harsanyi,PhD
- Chairman of the Board
- 535.98K
- Sujata Dayal
- Director
- 382.23K
- Neal F. Fowler
- Independent Director
- 398.75K
- General George A. Joulwan
- Independent Director
- 41.83K
- Ronald B. Richard
- Independent Director
- 394.73K
- Donald W. DeGolyer
- Independent Director
- 397.50K
- Dr. Louis W. Sullivan, M.D.
- Independent Director
- 400.23K
- Dr. Kathryn C. Zoon, PhD
- Independent Director
- 413.48K
- Keith A. Katkin
- Independent Director
- 396.99K
- Marvin L. White
- Independent Director
- 405.98K
Trending US Stocks
U.S. Crypto Concept Stocks U.S. Crypto Concept Stocks
Companies involved in the creation, trade, and services of digital forms of money.Displayed third-party logos, brands, or trademark images on screens or web pages are only for identification purposes and remain the property of their respective owners.Displayed third-party logos, brands, or trademark images on screens or web pages are only for identification purposes and remain the property of their respective owners. Information is provided by Futu and is a non-exhaustive list of all thematic stocks for reference purposes only.
This section presents the top 5 stocks in U.S. Crypto Concept Stocks, ranked from highest to lowest based on real-time market data. Companies involved in the creation, trade, and services of digital forms of money.Displayed third-party logos, brands, or trademark images on screens or web pages are only for identification purposes and remain the property of their respective owners.Displayed third-party logos, brands, or trademark images on screens or web pages are only for identification purposes and remain the property of their respective owners. Information is provided by Futu and is a non-exhaustive list of all thematic stocks for reference purposes only.
This section presents the top 5 stocks in U.S. Crypto Concept Stocks, ranked from highest to lowest based on real-time market data.
